Report of Foreign Issuer (6-k)
June 27 2018 - 9:29AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
For the month of June 2018
Commission File Number: 001-37643
KITOV PHARMA
LTD.
(Translation of registrant's name into English)
One
Azrieli Center, Round Tower,
Tel
Aviv 6701101, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark
if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
On June 27, 2018, Kitov Pharma Ltd. (the
“Company” or the “Registrant”) issued a press release, “
Kitov to Host Business Update Conference
Call on Monday, July 2
”, which is attached hereto as Exhibit 99.1
Attached hereto are the following exhibits:
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
KITOV PHARMA LTD.
|
|
|
June 27, 2018
|
By:
|
/s/ Simcha Rock
|
|
|
Simcha Rock
|
|
|
CFO and Director
|
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Sep 2023 to Sep 2024